These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1848898)

  • 1. Management of low-risk metastatic gestational trophoblastic tumors.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
    J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease.
    Weed JC; Barnard DE; Currie JL; Clayton LA; Hammond CB
    Obstet Gynecol; 1982 Mar; 59(3):377-80. PubMed ID: 6176924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT; Clarke-Pearson D; Hammond CB
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Oct; 19(2):173-81. PubMed ID: 6208089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
    Khoo SK; Jones IS
    Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
    Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
    Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
    Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
    Kohorn EI
    J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
    Surwit EA; Childers JM
    J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trends in the treatment of trophoblastic tumors].
    Giardina G; Durando C; Devalle G; Borgno G
    Minerva Ginecol; 1978 Oct; 30(10):893-6. PubMed ID: 214728
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
    Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
    Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.